Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
We are maintaining a long-term Neutral recommendation on Reinsurance Group of America Inc. ( RGA - Analyst Report ) .
Reinsurance Group has maintained its competitive position in North America by growing Facultative Reinsurance, Automatic Reinsurance and In Force Block Reinsurance, emphasizing its underwriting standards, prompt response on quotes, competitive pricing, capacity and flexibility in meeting customer needs.
The acquisition of ReliaStar’s group life and health reinsurance business in 2009 has consolidated its position in the North American reinsurance market. The combined strength of RGA Canada and former ING Reinsurance makes for a stronger company in the Canadian market and a larger market share.
Reinsurance Group is focused on growing its international operations to reap the benefits of diversification. Management eyes key Asian markets particularly India and China, which represent longer-term significant opportunities given the low reinsurance penetration in these markets.
Management expects $100 million in earned premium in 3 years in India and it will be applying for a license to operate in China in 2011. It has also opened an office in September 2010 in Middle East. For 2011, management expects premium from Canada to increase in the range of 5–7%, and premiums from Asia-Pacific and Europe & South Africa to increase in the range of 10–15% each.
Moreover, consolidation within the life reinsurance market in recent years makes it attractive for the company which holds a leading position in the same.
However, the primary factors to our Neutral recommendation are Reinsurance Group’s reliance on availability for affordable retrocession. The company had increased the maximum amount of coverage that it retains per life in the U.S. from $6.0million to $8.0million. This reduces the amount of premiums it pays to retrocessionaires, but increases the maximum effect a single death claim can have on its results, and therefore may result in additional volatility to its results.
Also interest rates are likely to remain low in 2011 and spreads narrow further. We expect to see additional pressure on the Reinsurance Group’s investment income. Moreover, management’s conservative positioning of the investment portfolio is expected to exert pressure on yield.
Over the long term we expect the company to fare well given its active capital management. Recently it retired Trust Preferred Income Equity Redeemable Securities (PIERS Units) and bought back enough shares to offset the dilution for the PIERS transaction. This has reduced the company’s debt burden.
The company also has excess capital to pursue meaningful mergers and acquisitions if opportunities arise. The recent dividend hike of 50% further reflects the company’s strong capital and liquidity position.
Reinsurance Group domiciled in Timberlake, Missouri, competes primarily with Munich Re, Swiss Re, General Re, a subsidiary of Berkshire Hathaway Inc. ( BRK.A - Snapshot Report ) ( BRK.B - Analyst Report ) . The stock carries a Zacks #3 Rank, which translates into a Hold recommendation over the short term (1–3 months).
Read the full reports :
Analyst Report on RGA
Analyst Report on BRK.B
Snapshot Report on BRK.A